Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds.
The purpose of this study was to examine the association between experimental rhinovirus infection and the elaboration of interleukin-8 (IL-8) into nasal secretions of volunteers and to determine the effect of pentoxifylline on IL-8 elaboration and rhinovirus-associated common cold symptoms. Fifty-four subjects with experimental rhinovirus infections and 20 sham-inoculated subjects were studied. Pentoxifylline had no effect on rhinovirus-induced symptoms or nasal-secretion IL-8 concentrations. IL-8 concentrations were significantly greater in nasal secretions from infected symptomatic subjects than in those from infected asymptomatic or sham-challenged subjects on days 2-4 after virus challenge. In infected subjects, there was significant rank correlation between nasal obstruction severity, rhinorrhea severity, and nasal-wash albumin concentrations and the change in IL-8 concentration from baseline on days 2-4 after virus challenge.
Turner
R B
RB
Department of Pediatrics, Medical University of South Carolina, Charleston 29425, USA.
Weingand
K W
KW
Yeh
C H
CH
Leedy
D W
DW
D000293:Adolescent; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D003139:Common Cold / Q000276:immunology* / Q000503:physiopathology* / Q000821:virology; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism*; D008875:Middle Aged; D017817:Nasal Lavage Fluid; D010431:Pentoxifylline / Q000008:administration & dosage; D012229:Rhinovirus / Q000276:immunology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016209:Interleukin-8; D010431:Pentoxifylline